Clenbuterol has not been approved by the U.S. Food and Drug Administration (FDA) as an ingredient for any drugs for humans, ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to ...

Per terms, Novo could pay up to $285 million in upfront and milestone fees to Ascendis, which specializes in a kind of ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

Compared with bronchodilator-only relievers ... All included trials of fast-onset, long-acting beta-agonists (alone or combined with an ICS) as a reliever therapy evaluated formoterol.

TURIN, Italy I October 30, 2024 I Kither Biotech, a clinical-stage biotech company focused on innovative therapies for respiratory diseases, today announced ...

DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Diwali is synonymous with fireworks but such celebrations contribute to air pollution by releasing particulate matter (PM10 ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...